Status:
COMPLETED
Tissue Sparing Surgery in Total Hip Arthroplasty
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Total Hip Arthroplasty
Hip Arthrosis
Eligibility:
All Genders
60-85 years
Phase:
NA
Brief Summary
Rationale of the study is to evaluate through a prospective randomized controlled study if a modified direct superior posterolateral approach (sperimental approach) to the hip articulation which entir...
Detailed Description
Rationale of the study is to evaluate through a prospective randomized controlled study if a modified direct superior approach (experimental approach) to the hip articulation which entirely spares i.e...
Eligibility Criteria
Inclusion
- Patients affected by:
- Non-inflammatory degenerative joint disease, including osteoarthritis
- Patients in the age from 60 to 85 included
- Consenting to actively participate in the study and in the rehabilitation follow up program as foreseen by the study
- 18 ≤ Body Mass Index (BMI) ≥ 30 kg/m2
- patient without contralateral THA
Exclusion
- Revision procedures where other treatments or devices have failed
- Active infection or suspected latent infection in or about the hip joint
- Bone stock that is inadequate for support or fixation of the prosthesis
- skeletal immaturity
- any mental or neuromuscular disorder that would create an unacceptable risk of prosthesis instability, prosthesis fixation failure or complication in post-operative care
- Obesity (BMI ≥30kg/m2)
Key Trial Info
Start Date :
April 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04358250
Start Date
April 26 2017
End Date
November 30 2018
Last Update
April 24 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy, 20161
2
Istituto Ortopedico Galeazzi
Milan, Italy, 20161